Clinical Trials Resources
Wilma Templin-Branner, M.S., Oak Ridge Institute
for Science and Education, Oak Ridge, Tennessee
Ms. Wilma Templin-Branner demonstrated the
electronic Clinical Trial Resource Guide, which
provides clinical researchers and other health
professionals with information about the clinical
trials resources of NIAID and other Federal
agencies and private organizations. The information
in the guide can help investigators to identify
and retain individuals in clinical trials, particularly
individuals in minority groups. Ms. Templin-Branner
also demonstrated a sampling of the Web sites
and databases included in the resource guide
that can be used to (1) identify relevant clinical
trials, (2) identify human subject policies,
(3) obtain information about funding sources
and mechanisms, and (4) learn how to prepare
successful grant applications.
The mini-CD includes topics that range from
appropriate human subjects policies to clinical
trials databases, a race and ethnicity bibliography,
cultural competence in health care, diversity
in clinical trials, funding, general clinical
trials Web sites, HIV/AIDS clinical trials Web
sites, PubMed, resources for diversity in clinical
trials, and women's health. Each of the topics
on the CD is linked to Internet resources that
are considered the most inclusive and reliable
sites on the topics. The sites were compiled
by the Office of Special Populations and Research
Training, the symposium steering committee,
the symposium speakers, and the Oak Ridge Institute
for Science and Education. Ms. Templin-Branner
asked symposium participants to e-mail her other
sites that should be included (templinw@orau.gov).
Ms. Templin-Branner pointed out some of the
information available on each of the topics,
including factsheets and order forms, computer-based
training, ethical guidelines, journal articles,
a grant application tutorial, and an HIV/AIDS
database. She emphasized that the Resource Guide
is intended to be as comprehensive and inclusive
as possible in presenting information on increasing
diversity in clinical trials, finding information
on specific populations, and attracting and
retaining minorities in clinical trials. She
demonstrated a search in PubMed and ClinicalTrials.gov. |